Kristen Brady, PA
Physician Assistant · Cincinnati, OHNPI 1114445079
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,721 of the $4,710 with a category attached, or 79.0%. It is spread thinly across 39 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,734, more than ten times the $105 reported in 2021. Among physician assistant clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 125 payments — averaging $37.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CTI Biopharma Corp.$700
- AbbVie$558
- Sanofi$558
- Pharmacyclics LLC, An Abbvie Company$245
- AstraZeneca$245
- E.r. Squibb & Sons, L.L.C.$229
- plus $2K from 33 others
Across 1 payment — averaging $1936.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$2K
What the payments were for
- Consulting fees$902%
- Speaking & faculty fees$70015%
- Food & beverage$3,72179%
- Education$1994%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CTI Biopharma Corp. | 1 | $700 |
| AbbVie | 19 | $558 |
| Sanofi | 9 | $558 |
| Pharmacyclics LLC, An Abbvie Company | 12 | $245 |
| AstraZeneca | 2 | $245 |
| E.r. Squibb & Sons, L.L.C. | 2 | $229 |
| Astellas Pharma US Inc | 7 | $225 |
| GSK | 4 | $180 |
| Novartis | 8 | $150 |
| Bristol Myers Squibb | 3 | $145 |
| Beigene USA, Inc. | 1 | $139 |
| Seagen Inc. | 3 | $136 |
| Pfizer | 5 | $94 |
| Johnson & Johnson | 5 | $92 |
| Janssen Scientific Affairs, LLC | 1 | $90 |
| Incyte Corporation | 4 | $80 |
| Cumberland Pharmaceuticals, Inc. | 3 | $76 |
| Lilly USA, LLC | 4 | $69 |
| Adaptive Biotechnologies Corporation | 3 | $67 |
| Taiho Oncology, Inc. | 3 | $60 |
| Amgen | 3 | $58 |
| Sobi, Inc | 2 | $53 |
| Invivyd Inc | 2 | $47 |
| Genmab U.S., Inc. | 2 | $44 |
| Sanofi-aventis U.S. LLC | 2 | $44 |
| Merck | 2 | $43 |
| Syndax Pharmaceuticals, Inc. | 1 | $33 |
| ADC Therapeutics America, Inc. | 1 | $28 |
| Fresenius Kabi USA, LLC | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Pharmaessentia USA Corporation | 1 | $23 |
| Genentech USA, Inc. | 1 | $23 |
| Rigel Pharmaceuticals, Inc. | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Recordati_rare_diseases_inc. | 1 | $19 |
| Beone Medicines USA, Inc. | 1 | $18 |
| Legend Biotech USA Inc. | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,710 in reported general payments places this provider in the 90th percentile of 4,098 physician assistant providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 30 | $20,851 |
| ValacyclovirValacyclovir Hcl | 52 | $3,400 |
| Fluconazole | 28 | $852 |
| Acyclovir | 44 | $550 |
| Ondansetron Hcl | 27 | $466 |
| Potassium Chloride | 35 | $388 |
| Levofloxacin | 39 | $354 |
| Gabapentin | 22 | $347 |
| Prochlorperazine Maleate | 21 | $230 |
| Dexamethasone | 13 | $156 |
| LoperamideLoperamide Hcl | 12 | $155 |
| Oxycodone Hcl | 15 | $138 |
| Doxycycline Hyclate | 14 | $120 |
| Zolpidem Tartrate | 15 | $48 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $94 | $20,85130 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,098 physician assistant providers in Ohio.
Other physician assistant in Cincinnati
- Steven WurzelbacherCincinnati$309K
- Melissa DoveCincinnati$41K
- Emily AnkromDayton$192K
- Amanda MaggartWorthington$164K
- Megan SevillaMayfield Heights$132K
- Erin StrculaBelpre$106K
- Sarah LaubNew Albany$100K
- Jessica RhominskiCanal Winchester$78K
- Brook GramBeloit$52K
- Alison FleigToledo$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.